Galantamine
- Product NDC
- 24979-723
- 11-digit product format
- 249790723
- Labeler code
- 24979
- Product ID
- 24979-723_4685d63a-b3bc-416d-e063-6294a90afce3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- galantamine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, LLC
- Application
- ANDA077604
- Marketing category
- ANDA
- Marketing start
- 2024-03-06
- Substance
- GALANTAMINE HYDROBROMIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Galantamine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GALANTAMINE HYDROBROMIDE | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MJ4PTD2VVW |
| Rxcui | 310436, 310437, 579148 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24979-723-04 | Galantamine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24979-723 | GALANTAMINE TABLET, FILM COATED [UPSHER-SMITH LABORATORIES, LLC] | 4 | Current NDC, 1 package rows | 20241208_10497273-d907-0514-e063-6294a90a1362.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 24979-723-04 | 24979072304 | 60 TABLET, FILM COATED in 1 BOTTLE (24979-723-04) | 2024-03-06 | No | No | Current |